Print
Email
Print Edition StoriesFriday, November 6, 2009
N.E. researchers share grants for infectious diseases
By Mass High Tech staff
Funding drugs for rare diseases
MHT's Julie Donnelly: Life science startups finding investments
MHT's Marc Songini: Mass. bio firms prep for lifting of stem cell ban
Three New England physicians are among eight researchers who will share $130 million in federal funds over the next five years under a research program designed to better understand the human immune response to emerging and re-emerging diseases, including those that may be the result of bioterrorism.
The grants were part of a $229 million initiative — including $21 million in federal recovery act funds — by the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health. The grants were awarded to the Cooperative Centers for Translational Research on Human Immunology and Biodefense and the Immune Mechanisms of Virus Control. Those centers operate with the long-term goal of identifying new vaccines and drug targets.
Among the eight investigators awarded five-year grants totalling $130 million were Raymond Chung at Massachusetts General Hospital, Anne de Groot of the University of Rhode Island, and Alan Rothman at the University of Massachusetts Medical Center in Worcester.
De Groot also serves as the CEO of EpiVAX and is founder of the Global Alliance to Immunize against AIDS. Chung is an associate professor of medicine at Harvard Medical School, and director of hepatology and medical director, of the liver transplant program at MGH. Rothman is a professor at UMass Medical School, conducting research on the Dengue virus and the hepatitis C virus.
RSS Feeds
Comments
Please Login/Register to post comments.
No comments have been added or approved.